Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-173.01%
-
106.13%
58.37%
40.68%
30.53%
ROA
-88.96%
-76.94%
-88.76%
-91.45%
-91.97%
-90.84%
Gross Margin
100%
100%
100%
100%
100%
100%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
-598.35%
-604.25%
-597.01%
-600.14%
-599.28%
-598.9%
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for OncoZenge AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
Total Assets
SEK 24,401.00K
SEK 22,605.52K
SEK 26,341.66K
SEK 30,130.32K
SEK 33,332.07K
SEK 35,144.72K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 15,940.00K
-SEK 18,083.22K
-SEK 21,722.92K
-SEK 25,822.09K
-SEK 29,183.21K
-SEK 31,100.88K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 169,330.65K
SEK 192,098.07K
SEK 230,762.67K
SEK 274,308.13K
SEK 310,013.25K
SEK 330,384.74K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 6.76
SEK 7.67
SEK 9.21
SEK 10.95
SEK 12.38
SEK 13.19
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
OncoZenge AB (publ) (ONCOZ.ST) Financial Forecast | Equlion
